Source: Basic and Clinical Pharmacology and Toxicology. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, METALOPROTEINASES, RECEPTORES IMUNOLÓGICOS
ABNT
CAU, Stefany B. A. et al. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension. Basic and Clinical Pharmacology and Toxicology, v. 117, n. 4, p. 234-241, 2015Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12400. Acesso em: 01 maio 2024.APA
Cau, S. B. A., Guimarães, D. A., Rizzi, E., Ceron, C. S., Gerlach, R. F., & Tanus-Santos, J. E. (2015). The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension. Basic and Clinical Pharmacology and Toxicology, 117( 4), 234-241. doi:10.1111/bcpt.12400NLM
Cau SBA, Guimarães DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 4): 234-241.[citado 2024 maio 01 ] Available from: https://doi.org/10.1111/bcpt.12400Vancouver
Cau SBA, Guimarães DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 4): 234-241.[citado 2024 maio 01 ] Available from: https://doi.org/10.1111/bcpt.12400